ImmuCell Corp. is a public biotechnology company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries. The company’s product focus is prevention, diagnosis and treatment of economically important bovine diseases. The company has a dedicated group of employees who are actively developing, manufacturing and selling innovative products such as First Defense®, the #1 product administered to calves for scours prevention. For more information, visit the company’s Website at www.immucell.com.
ImmuCell Corp. (ICCC) Starts Presentation at LD Micro Conference
Previous Article
Next Article
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option